Evidence map›Paper›PMID 39542888›Full record

ReviewSurgical endoscopy2024

Upcoming multi-visceral robotic surgery systems: a SAGES review.

Ankit Sarin, Sarah Samreen, Jennifer M Moffett, Edmundo Inga-Zapata, Francesco Bianco, Nawar A Alkhamesi, Jacob D Owen, Niti Shahi, Jonathan C DeLong, Dimitrios Stefanidis and 4 more

Abstract readReview
In one paragraph

Review in Surgical endoscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Observational
  12. [Advances in the application of transoral robotic surgery].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ankit SarinUniversity of CA - Davis Health, 6th Floor, 2335 Stockton Blvd., Sacramento, CA, 95817, USA. axsarin@ucdavis.edu.ORCID 0000-0001-5671-2267
Sarah SamreenUniversity of Texas Medical Branch, Galveston, TX, USA.
Jennifer M MoffettUniversity of Texas Medical Branch, Galveston, TX, USA.
Edmundo Inga-ZapataSurgical Research Lab, Larkin Health System, Miami, FL, USA.
Francesco BiancoUniversity of Illinois at Chicago, Chicago, IL, USA.
Nawar A AlkhamesiWestern University and London Health Sciences Centre, London, ON, Canada.
Jacob D OwenECU Health Medical Center, Greenville, NC, USA.
Niti ShahiUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Jonathan C DeLongUniversity of Tennessee Medical Center, Knoxville, TN, USA.
Dimitrios StefanidisIndiana University School of Medicine, Indianapolis, IN, USA.
Christopher M SchlachtaSchulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Patricia SyllaMount Sinai Health System, New York, NY, USA.
Dan E AzaguryStanford University School of Medicine, Stanford, CA, USA.
SAGES Robotic Platforms Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRobotic surgical procedures continue to increase both in the United States (US) and worldwide. Several novel robotic surgical platforms are under development or undergoing regulatory approval. This review explores robotic platforms that are expected to reach US consumers within the next 2-3 years.

methodsThe SAGES Robotic Platforms Working Group identified robotic surgery platforms in various stages of development and selected multi-visceral systems nearing or completing the US Food and Drug Administration (FDA) approval process. We outline key system components including architecture, unique features, development status, regulatory approval, and expected markets.

resultsWe identified twenty robotic platforms that met our selection criteria. Ten companies were based in North America, and ten were based in Europe or Asia. Each system is described in detail and key features are summarized in table form for easy comparison.

conclusionThe emergence of novel robotic surgical platforms represents an important evolution in the growth of minimally invasive surgery. Increased competition has the potential to bring value to surgical patients by stimulating innovation and driving down cost. The impact of these platforms remains to be determined, but the continued growth of robotic surgery seems to be all but assured.

Indexed as

Robotic Surgical ProceduresEquipment DesignHumansLaparoscopyMinimally Invasive Surgical ProceduresUnited StatesVisceraImagingInnovationRobotic platformsRobotic surgerySurgical architectureTelemedicine

Identifiers

PMID39542888
PMCPMC11615118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.